|
|
Ann Rheum Dis. 2002 January; 61(1): 1–3. doi: 10.1136/ard.61.1.1-a. | PMCID: PMC1753875 |
Steroids cause osteoporosis S Paget The Full Text of this article is available as a PDF (86K). These references are in PubMed. This may not be the complete list of references from this article. - Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med. 1994 Feb;96(2):115–123. [PubMed]
- Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ. 1996 Aug 10;313(7053):344–346. [PubMed]
- Soucy E, Bellamy N, Adachi JD, Pope JE, Flynn J, Sutton E, Campbell J. A Canadian survey on the management of corticosteroid induced osteoporosis by rheumatologists. J Rheumatol. 2000 Jun;27(6):1506–1512. [PubMed]
- Lepore L, Salvatore CM, Pahor T, Kiren V, Ventura A. Slow evolution to systemic lupus erythematosus of isolated autoimmune thrombocytopenia. Clin Exp Rheumatol. 2000 Jul–Aug;18(4):535. [PubMed]
- Goldring SR, Gravallese EM. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res. 2000;2(1):33–37. [PubMed]
- Peat ID, Healy S, Reid DM, Ralston SH. Steroid induced osteoporosis: an opportunity for prevention? Ann Rheum Dis. 1995 Jan;54(1):66–68. [PubMed]
- Gudbjornsson B, Juliusson UI, Gudjonsson FV. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann Rheum Dis. 2002 Jan;61(1):32–36. [PubMed]
- Hougardy DM, Peterson GM, Bleasel MD, Randall CT. Is enough attention being given to the adverse effects of corticosteroid therapy? J Clin Pharm Ther. 2000 Jun;25(3):227–234. [PubMed]
- Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med. 1998 Jul 30;339(5):292–299. [PubMed]
- Reid DM, Hughes RA, Laan RF, Sacco-Gibson NA, Wenderoth DH, Adami S, Eusebio RA, Devogelaer JP. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res. 2000 Jun;15(6):1006–1013. [PubMed]
- Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest. 1998 Oct 15;102(8):1627–1633. [PubMed]
|
